Schneyer Mark C. sold ACAD
October 30, 2026 · Form 4 insider transaction
Schneyer Mark C. sold 3,321 shares of Acadia Pharmaceuticals Inc. at $20.88 per share, a transaction worth $69.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,321
Price
$20.88
Total value
$69.3K
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 30, 2026
Filing dateOctober 30, 2026
Shares owned after71,322
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).